A two-year, £2 million project focused on gene and cell therapy manufacturing will be embarked on by Oxford BioMedica, will embark on.
Go to Page Go
your submission has already been received.
OK
Please enter a valid Email address!
Submit
The most relevant industry news & insight will be sent to you every two weeks.